Skip to main content
×
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 5
  • Cited by
    This chapter has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Kawabata, Yoshinori Kasai, Takahiko Kobashi, Yoichiro Kawahara, Kunimitsu Uekusa, Toshimasa Kurashima, Kazuyoshi and Shimizu, Yoshihiko 2018. Grade 4 asbestosis does not extend directly from the respiratory bronchiole to the peripheral lung. Histopathology, Vol. 73, Issue. 1, p. 29.

    Sporn, Thomas A. and Roggli, Victor L. 2016. A hard (metal) case: Value of analytical scanning electron microscopy. Ultrastructural Pathology, Vol. 40, Issue. 3, p. 147.

    Carney, John McAdams, Page McCluskey, James and Roggli, Victor L. 2016. Aluminum-induced pneumoconiosis confirmed by analytical scanning electron microscopy: A case report and review of the literature. Ultrastructural Pathology, Vol. 40, Issue. 3, p. 155.

    Altınsoy, Bülent Öz, İbrahim İlker Erboy, Fatma Tor, Meltem and Atalay, Figen 2016. Emphysema and Airflow Obstruction in Non-Smoking Coal Miners with Pneumoconiosis. Medical Science Monitor, Vol. 22, Issue. , p. 4887.

    Sporn, Thomas A. and Roggli, Victor L. 2014. Pathology of Asbestos-Associated Diseases. p. 53.

    ×
  • Print publication year: 2000
  • Online publication date: June 2014

Chapter 14 - Occupational lung disease

Summary

Introduction

Occupational lung disease is the most significant form of work-related illness in the United States in terms of its severity, frequency and cost to society. The US Department of Labor reported the occurrence of some 4.1 million workplace injuries and illnesses in 2006, including 17 700 respiratory ailments in private industry alone and an incidence of non-fatal occupational respiratory illness of 1.9 cases per 10 000 full-time workers. Occupational lung diseases result in one of the most significant causes of lost work productivity, with the highest rate of days away from work due to respiratory illness sustained by the mining industry. Occupational lung diseases are the third most prevalent (246 per 100 000 population) in the European Union, also with the highest proportion found in the mining industry. Technological advances in construction have led to new groups of at-risk workers in addition to the traditional occupations in mining and quarry work. Global estimates of disability and disease resultant from occupational exposure to airborne particulates also include 386 000 deaths from pneumoconiosis, asthma and other chronic obstructive lung diseases.

The toll that occupational lung diseases exact upon society is reflected in estimated direct and indirect costs that number in the billions of dollars. Occupational lung diseases cause significant morbidity, which usually lacks curative medical intervention at the time of presentation, apart from jobsite or occupation modification. Stringent oversight of workplace conditions and permissible exposures on the part of governments and regulatory agencies, along with the retention of occupational health physicians on the part of larger firms, will hopefully mitigate the development of severe disease in the future.

Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Spencer's Pathology of the Lung
  • Online ISBN: 9781139018760
  • Book DOI: https://doi.org/10.1017/CBO9781139018760
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×
References
National Institute for Occupational Safety and Health. Work-Related Lung Disease Surveillance Report. December 2002.
US Department of Labor. Bureau of Labor Statistics. Workplace Injuries and Illnesses in 2006. October 16 2007.
Centers for Disease Control and Prevention. National Institute for Occupational Safety and Health. Work-Related Lung Disease (WoRLD) Surveillance System. May 2003.
Sigsgaard, T, Nowak, D, Annesi-Maesano, I, et al. and ERS EOH group 6.2. ERS Position Paper: Work-related respiratory diseases in the EUEur Respir J 2010;35:234–8.
Driscoll, T, Nelson, D, Steenland, K, et al. The global burden of non-malignant respiratory disease due to occupational airborne exposuresAm J Ind Med 2005;6:432–45.
Leigh, JP, Markowitz, SB, Fahs, M, Shin, C, Landrigan, PJ.Occupational injury and illness in the United States. Estimates of costs, morbidity and mortality. Arch Int Med 1997;157(14):1557–68.
US Department of Health and Human Services. Public Health Service. Progress Review: Healthy People 2010. Focus Area 20 – Occupational Safety and Health.
Dave, SK, Beckett, WS.Occupational exposure and predictable asbestos-related diseases in India. Am J Ind Med 2005;48:137–43.
Sporn, TA.The mineralogy of asbestos. Rec Res Cancer Res 2011;189:1–11.
Neri, M, Ugolini, D, Dianzani, I, Gemignani, et al. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat Res 2008;659:126–35.
Darcy, DJ, Alleman, T. Chapter 2. In Roggli, VL, Oury, TD, Sporn, TA, eds. Pathology of Asbestos-Associated Diseases, 2nd ed. New York: Springer, 2004. pp. 17–33.
Wagner, JC, Sleggs, CA, Marchand, P.Diffuse pleural mesothelioma and asbestos exposure in Northwestern Cape Province. Br J Ind Med 1960;17:260–71.
Smith, MJ, Naylor, B.A method for extracting ferruginous bodies from sputum and pulmonary tissues. Am J Clin Pathol 1972;58:250–4.
Roggli, VL, McGavran, MH, Subach, JA, Sybers, HD, Greenberg, SD.Pulmonary asbestos body counts and electron probe analysis of asbestos body cores in patients with mesothelioma: A study of 25 cases. Cancer 1982;50:2423–32.
Gylseth, B, Churg, A, Davis, JM G, et al. Analysis of asbestos fibers and asbestos bodies in tissue samples from human lung: an international interlaboratory trial. Scand J Work Environ Health 1987;11:107–10.
Hansen, J, de Klerk, NH, Eccles, JL, et al. Malignant mesothelioma after environmental exposure to blue asbestos. Int J Cancer 1993;54:578–81.
Berry, M.Mesothelioma incidence and community asbestos exposure. Environ Res 1997;75:34–40.
Roggli, VL, Vollmer, RT, Butnor, KJ, Sporn, TA.Tremolite and mesothelioma. Ann Occup Hyg 2002;46:447–53.
Srebro, SH, Roggli, VL.Asbestos-related disease associated with exposure to asbestiform tremolite. Am J Ind Med 1994;26:809–19.
Roggli, VL, Longo, WE.Mineral fiber content of lung tissue in patients with environmental exposures: household contacts vs. building occupants. Ann NY Acad Sci 1992;643:511–19.
Pan, X-L, Day, HW, Wang, W, Beckett, LA, Schenker, MD.Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med 2005;172:1019–25.
Kurumatani, N, Kumagai, S.Mapping the risk of mesothelioma due to neighborhood asbestos exposure. Am J Respir Crit Care Med 2008;178:624–9.
Roggli, VL, Sharma, A, Butnor, KJ, Sporn, TA, Vollmer, RT.Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases. Ultrastruct Pathol 2002;26:55–65.
Howel, D, Gibbs, A, Arblaster, L, et al. Mineral fiber analysis and routes of exposure to asbestos in the development of mesothelioma in an English region. Occup Environ Med 1999;56:51–8.
Anderson, HA, Lilis, R, Daum, SM, Selikoff, IJ.Asbestosis among household contacts of asbestos factory workers. Ann NY Acad Sci 1979;330:387–99.
Newhouse, ML, Thompson, H.Mesothelioma of pleura and peritoneum following exposure to asbestos in the London area. Br J Ind Med 1965;22:261–9.
Whitwell, F, Scott, J, Grimshaw, M.Relationship between occupations and asbestos fibre content of lungs in patients with pleural mesothelioma, lung cancer and other diseases. Thorax 1977;32:377–86.
Huncharek, M, Capotorto, JV, Muscat, J.Domestic asbestos exposure, lung fibre burden and pleural mesothelioma in a housewife. Br J Ind Med 1989;46:354–5.
Gibbs, AR, Griffiths, DM, Pooley, FDJones, JSP.Comparison of fibre types and size distributions on lung tissues of paraoccupational and occupational cases of malignant mesothelioma. Br J Ind Med 1990;47:621–6.
Roggli, VL, Sharma, A.Analysis of tissue mineral fiber content, Chapter 11. In Roggli, VL, Oury, TD, Sporn, TA, eds. Pathology of Asbestos-Associated Diseases, 2nd ed. New York: Springer, 2004. pp. 309–54.
Roggli, VL, Oury, TD, Moffatt, EJ.Malignant mesothelioma in women. In Rosen, PP, Fechner, Re, eds. Anatomic Pathology, vol. 2. Chicago: ASCP Press, 1998, pp. 147–63.
Roggli, VL.Asbestos bodies and non-asbestos ferruginous bodies, Chapter 3. In Roggli, VL, Oury, TD, Sporn, TA, eds. Pathology of Asbestos-Associated Diseases, 2nd ed. New York: Springer, 2004. pp. 34–70.
Roggli, VL, Benning, TL.Asbestos bodies in pulmonary hilar lymph nodes. Mod Pathol 1990;3:513–17.
Hammar, SP, Dodson, RF.Asbestos, Chapter 27. In Tomashefski, JF, Cagle, PT, Farber, CF, Fraire, AE, eds. Dail and Hammar's Pulmonary Pathology, 3rd ed. New York: Springer, 2008. pp. 950–1031.
Churg, AM, Warnock, ML.Analysis of the cores of ferruginous (asbestos) bodies from the general population: III, Patients with environmental exposures. Lab Invest 1979;40:622–6.
Mowe, G, Gylseth, B, Hartveit, F, Skaug, V.Fiber concentrations in lung tissue of patients with malignant mesothelioma: a case-control study. Cancer 1985;56:1089–93.
Gaudichet, A, Janson, X, Monchaux, G, et al. Assessment by analytical microscopy of the total lung fibre burden in mesothelioma patients matched with four other pathological series, Ann Occup Hyg 1988;32(suppl 1):213–23.
Churg, A, Warnock, ML.Asbestos fibers in the general population. Am Rev Respir Dis 1980;122:669–78.
Case, BW, Sebastien, P.Environmental and occupational exposures to chrysotile asbestos: a comparative microanalytic study. Arch Environ Health 1987;42:185–91.
Srebro, SH, Roggli, VL, Samsa, GP.Malignant mesothelioma associated with low pulmonary tissue asbestos burdens: a light and scanning electron microscopic analysis of 18 cases. Mod Pathol 1995;8:614–21.
Lee, KP.Lung response to particulates with emphasis on asbestos and other fibrous dusts. Crit Rev Toxicol 1985;14:33–86.
Timbrell, V.Aerodynamic Considerations and Other Aspects of Glass Fiber. Washington DC: HEW, 1976. pp. 33–53.
Timbrell, V.Deposition and retention of fibers in the human lung. Ann Occup Hyg 1982;26:347–69.
Ashgarian, B, Yu, CP.Deposition of inhaled fibrous particles in the human lung. J Aerosol Med 1988;1:37–50.
Churg, A.Deposition and clearance of chrysotile. Ann Occup Hyg 1994;38:625–34.
Davis, JMG, Addison, J, Bolton, RE, et al. The pathogenesis of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol 1986;67:415–30.
Davis, JMG, Jones, A.Comparison of the pathogenicity of long and short fibres of chrysotile in rats. Br J Exp Pathol 1988;69:717–37.
Boutin, C, Dumortier, P, Rey, F.Black spots concentrate oncogenic fibers in the parietal pleura. Am J Respir Crit Care Med 1996;153:444–9.
Mitchev, K, Dumortier, P, DeVuyst, P.Black spots and hyaline pleural plaques on the parietal pleura of 150 urban necropsy cases. Am J Surg Pathol 2002;26:1198–206.
Gloyne, SR.The presence of the asbestos fibre in the lesions of asbestos workers. Tubercle 1929;10:404–7.
Castleman, BI.Asbestos: Medical and Legal Aspects. New York: Harcourt Brace Jovanovich, 1984.
Roggli, VL.Pathology of human asbestosis: a critical review. In Fenoglio-Preiser, CM, ed. Advances in Pathology, vol. 2. Chicago: Yearbook Publishing, 1989. pp. 31–60.
Ghio, AJ, Churg, A, Roggli, VL.Ferruginous bodies: implications in the mechanism of fiber and particle toxicity. Toxicol Pathol 2004;32:643–49.
Ghio, AJ, LeFurgey, A, Roggli, VL.In vivo accumulation of iron on crocidolite is associated with decrements in oxidant generation by the fiber. J Toxicol Environ Health 1997;50:125–42.
Governa, MM, Amati, M.Role of iron in asbestos body induced oxidant radical generation, J Toxicol Environ Health 2009;58:279–87.
Churg, AM, Warnock, ML.Asbestos and other ferruginous bodies: their formation and clinical significanceAm J Pathol 1981;102:447–56.
Morgan, A, Holmes, A.Concentrations and dimensions of coated and uncoated asbestos fibers in the human lung. Br J Ind Med 1980;37:25–32.
Morgan, A, Holmes, A.The enigmatic asbestos body: its formation and significance in asbestos-related disease. Environ Res 1982;38:283–92.
Dodson, RF, Williams, MG, O'Sullivan, MF, et al. A comparison of the ferruginous body and uncoated fiber content in the lungs of former asbestos workers. Environ Res 1982;28:171–8.
Miller, A, Teirstein, AS, Bader, MD, Bader, RA, Selikoff, IJ.Talc pneumoconiois: significance of sublight microscopic mineral particles. Am J Med 1971;50:395–402.
Karjalainen, A, Nurminen, M, Vanhala, E, Vainio, H, Anttila, S.Pulmonary asbestos bodies and asbestos fibers as indicators of exposure. Scand J Work Environ Health 1986;22:34–8.
Churg, A.Fiber counting and analysis in the diagnosis of asbestos-related disease. Hum Pathol 1982;13:381–92.
Churg, A.Neoplastic asbestos-induced disease, Chapter 10. In Churg, A, Green, FHY, eds. Pathology of Occupational Lung Disease, 2nd ed. Baltimore: Williams –Wilkins, 1998.
Gross, P, Tuma, J, deTreville, RT P.Unusual ferruginous bodies: their formation from non-fibrous particulates and from carbonaceous fibrous particles. Arch Environ Health 1971;22:534–37.
Sporn, TA, Roggli, VL.Asbestosis, Chapter 4. In Roggli, VL, Oury, TD, Sporn, TA, eds. Pathology of Asbestos-Associated Diseases, 2nd ed. New York: Springer, 2004. pp. 71–103.
Kilburn, KH, Lilis, R, Anderson, HA, Miller, A, Warshaw, RH.Interaction of asbestos, age and smoking in producing radiographic evidence of diffuse pulmonary fibrosis. Am J Med 1986;80:377–81.
Barnhart, S, Thornquist, M, Omenn, GS, et al. The degree of roentgenographic parenchymal opacities attributable to smoking among asbestos-exposed subjects. Am Rev Respir Dis 1990;141:1102–6.
Antao, VC, Pinheiro, GA, Wassell, JT.Asbestosis mortality in the United States: facts and predictions. Occup Environ Med 2009;66:335–8.
Bang, KM, Mazurek, JM, Syamlal, G, Wood, JM.Asbestosis mortality surveillance in the United States 1970–2004. Int J Occup Env Health 2008;14:161–9.
Churg, AM, Green, FHY.Occupational lung disease, Chapter 24. In Churg, A, Myers, JL, Tazelar, H, Wright, JL, eds. Thurlbeck's Pathology of the Lung, 3rd ed. New York: Thieme, 2005. p. 769.
Tan, RJ, Fattman, CL, Niehouse, LM, Tobolewski, JM, et al. Matrix metalloproteinases promote inflammation and fibrosis in asbestos-induced lung injury in mice. Am J Respir Cell Mol Biol 2006;35:289–97.
Mossman, BT, Gee, JB L.Asbestos-related diseases. N Engl J Med 1989;320:1721–30.
Robledo, R, Mossman, BT.Cellular and molecular mechanisms of asbestos-induced fibrosisJ Cell Physiol 1999;180:158–66.
Mossman, BT, Borm, PJ, Castranova, V, et al. Mechanisms of action of inhaled fibers, particles and nanoparticles in lung and cardiovascular diseases. Part Fibre Toxicol 2007;4:4.
Mossman, BT, Churg, A.State of the art: mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 1998;157:1666–80.
Hirvonen, A, Saarikoski, ST, Linnnainmaa, K, et al. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J Natl Cancer Inst 1996;88:1853–6.
Kelsey, KT, Nelson, HH, Wiencke, JK, Smith, CM, Levin, S.The glutathione s-transferase theta and mu deletion polymorphisms in asbestosisAm J Ind Med 1997;31:274–9.
Franko, A, Dodic-Fikfak, M, Arneric, N, Dolzan, V.Glutathione S-transferases GSTMA and GSTT1 polymorphisms and asbestosis. J Occup Environ Med 2007;49:667–71.
Franko, A, Dolzan, V, Arneric, N, Dodic-Fikfak, M.The influence of genetic polymorphisms of GTSP1 on the development of asbestosis. J Occup Environ Med 2008;50:7–12.
Jakobsson, K, Rannug, A, Alexandrie, A-K, et al. Genetic polymorphism for glutathione-S-transferase mu in asbestos cement workersOccup Environ Med 1994;51:812–16.
Singhal, SS, Saxena, M, Ahmad, H, et al. Glutathione S transferases of human lung: characterization and evaluation of the alpha-class isoenzymes against lipid peroxidation. Arch Biochem Biophys 1992;299:232–41.
Roach, HD, Davies, GJ, Atanoos, R, et al. Asbestos: when the dust settles – an imaging review of asbestos-related disease. Radiographics 2002;22:s167–84.
Aberle, DR, Gamsu, G, Ray, CS, Feuerstein, IM.Asbestos-related pleural and parenchymal fibrosis: detection with high resolution CT. Radiol 1988;166:729–34.
Friedman, AC, Fiel, SB, Fisher, MS, et al. Asbestos-related pleural disease and asbestosis: a comparison of CT and chest radiography. Am J Roentgenol 1988;150:269–75.
American Thoracic Society. The diagnosis of non-malignant diseases related to asbestos. Am Rev Respir Dis 1986;134:363–8.
American Thoracic Society Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med 2004;170:691–715.
Craighead, JE, Abraham, JL, Churg, A, et al. The pathology of asbestos associated diseases of the lung and pleural cavities: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the American College of Pathologists and the National Institute for Occupational Safety and Health. Arch Pathol Lab Med 1982;106:543–96.
Henderson, DW, Rantanen, J, Barnhart, S, et al. Asbestos, asbestosis and cancer: the Helsinki criteria for diagnosis and attribution. A consensus report of an international expert group. Scand J Work Environ Health 1997;23:311–16.
Roggli, VL, Gibbs, AR, Attanoos, R, et al. Pathology of asbestosis – an update of the diagnostic criteria. Report of the Asbestosis Committee of the College of American Pathologists and Pulmonary Pathology Society. Arch Pathol Lab Med 2010;134:462–80.
Roggli, VL, Pratt, PC.Numbers of asbestos bodies on iron stained sections in relation to asbestos body counts in lung tissue digests. Hum Pathol 1983;14:355–61.
De Vuyst, P, Dumortier, P, Moulin, E, Yourassowsky, N, Yernault, JC.Diagnostic value of asbestos bodies in bronchoalveolar lavage fluid. Am Rev Respir Dis 1987;134:363–8.
Teschler, H, Friedrichs, KH, Hoheisel, GB, et al. Asbestos fibers in bronchoalveolar lavage and lung tissue of former asbestos workers. Am J Respir Crit Care Med 1994;149:641–5.
Roggli, VL.Scanning electron microscopic analysis of mineral fiber content of lung tissue in the evaluation of diffuse pulmonary fibrosis. Scanning Microsc 1991;5:71–83.
Gaensler, EA, Jederlinic, PJ, Churg, A.Idiopathic pulmonary fibrosis in asbestos-exposed workers. Am Rev Respir Dis 1991;144:689–96.
Schneider, F, Sporn, TA, Roggli, VL.Asbestos fiber content of lungs with diffuse interstitial fibrosis. Arch Pathol Lab Med 2010;134:457–61.
Huuskonen, MS.Clinical features, mortality and survival of patients with asbestosis. Scand J Work Environ Health 1978;4:265–74.
Berry, G.Mortality of workers certified by a pneumoconiosis reference panel as having asbestosis. Br J Ind Med 1981;38:130–7.
Murai, Y, Kitagawa, M.Autopsy cases of asbestosis in Japan: a statistical analysis on registered casesArch Environ Health 2000;55:447–52.
Selikoff, IJ, Hammond, EC, Seidman, H.Mortality experience of insulation workers in the United States and Canada, 1943–1976. Ann NY Acad Sci 1979;330:91–116.
Kipen, HM, Lilis, R, Suzuki, Y, Valciukas, JA, Selikoff, IJ.Pulmonary fibrosis in asbestos insulation workers with lung cancer: a radiological and histopathological evaluation. Br J Ind Med 1987;44:96–100.
McDonald, AD, McDonald, JC.Malignant mesothelioma in North America. Cancer 1980;46:1650–6.
Gloyne, SR.Two cases of squamous carcinoma of the lung occurring in asbestosis. Tubercle 1935;17:5–10.
Lynch, KM, Smith, WA.Pulmonary asbestosis III. Carcinoma of the lung in asbestos-silicosis. Am J Cancer 1935;24:56–64.
Breslow, L.Industrial aspects of bronchogenic neoplasms. Dis Chest 1955;28:421–30.
Doll, R.Mortality from cancer of the lung in asbestos workers. Br J Ind Med 1955;12:81–6.
Henderson, DW, de Klerk, NH, Hammer, SP, et al. Asbestos and lung cancer: is it attributable to asbestosis or asbestos fibre burden? Chapter 6. In Corrin, B, ed. Pathology of Lung Tumors. London: Churchill Livingstone, 1997. pp. 83–118.
Roggli, VL.Carcinoma of the lung, Chapter 7. In Roggli, VL, Oury, TD, Sporn, TA, eds. Pathology of Asbestos-Associated Diseases, 2nd ed. New York: Springer, 2004. pp.193–216.
Wagner, JC, Berry, G, Skidmore, JW, Timbrell, V.The effects of the inhalation of asbestos in rats. Br J Cancer 1974;29:252–69.
Selikoff, IJ, Churg, J, Hammond, EC.Asbestos exposure, smoking and neoplasia. JAMA 1968;204:104–10.
Fattman, CL, Chu, CT, Oury, TD.Experimental models of asbestos-related diseases, Chapter 10. In Roggli, VL, Oury, TD, Sporn, TA, eds. Pathology of Asbestos-Associated Diseases, 2nd ed. New York: Springer, 2004. pp. 256–308.
Hodgson, J, Darnton, A.The quantitative risk of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 2000;44:565–601.
Berman, DW, Crump, KS.Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol 2008;38(S1):1–47.
Berman, DW, Crump, KS.A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol 2008;38(S1):49–73.
Hein, MJ, Stayner, LT, Leyman, E, Dement, JM.Follow up study of chrysotile textile workers: cohort mortality and exposure response. Occup Environ Med 2007;64:616–25.
Churg, A.Asbestos, asbestosis and lung cancer. Mod Pathol 1993;6:509–10.
Henderson, DW, Rodelsperger, K, Woitowitz HJ Leigh, J.After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997–2004. Pathology 2004;36:517–50.
Gibbs, A, Attanoos, RL, Churg, A, Weill, H.The “Helsinki criteria” for attribution of lung cancer to asbestos exposure: how robust are the criteria?Arch Pathol Lab Med 2007;131:181–4.
Roggli, VL, Hammar, SP, Maddox, JC, Henderson, DW.The “Helsinki criteria” for attribution of lung cancer to asbestos exposure: how robust are the criteria?Arch Pathol Lab Med 2008;132:1386–7.
Karjalainen, A, Anttila, S, Vanhala, E, Vainio, H.Asbestos exposure and the risk of lung cancer in a general urban population. Scand J Work Environ Health 1997;20:243–50.
Roggli, VL, Sanders, LL.Asbestos content of lung tissue and carcinoma of the lung: a clinicopathologic correlation and mineral fiber analysis of 234 cases. Ann Occup Hyg 2000;44:109–17.
Mark, EJ.The second diagnosis: the role of the pathologist in identifying pneumoconiosis in lungs excised for tumor. Hum Pathol 1981;12:585–7.
Whitwell, F, Scott, J, Grimshaw, M.Relationship between occupations and asbestos fibre content of the lungs in patients with pleural mesothelioma, lung cancer and other diseases. Thorax 1977;32:377–86.
Ashcroft, T, Heppleston, AG.The optical and electron microscopic determination of pulmonary asbestos fiber concentration and its relation to the human pathologic reaction. J Clin Pathol 1973;26:224–34.
Banks, DE, Shi, R, McLarty, J, et al. American College of Chest Physicians Consensus Statement on the Respiratory Health Effects of Asbestos: Results of a Delphi Study. Chest 2009;135:1619–27.
Morgan, A, Holmes, A.Distribution and characteristics of amphibole asbestos fibres in the left lung of an insulation worker measured with the light microscope. Br J Ind Med 1983;40:45–50.
Langer, AM, Mackler, AD, Pooley, FD.Electron microscopical investigation of asbestos fibers. Environ Health Persp 1974;9:63–80.
Pooley, FD.The identification of asbestos dust with an electron microscope analyzer. Ann Occup Hyg 1975;18:181–6.
Churg, A, Sakoda, N, Warnock, ML.A simple method for preparing ferruginous bodies for electron microscopic examination. Am J Clin Pathol 1977;68:513–17.
Roggli, VL.Tissue digestion techniques, Appendix. In Roggli, VL, Oury, TD, Sporn, TA, eds. Pathology of Asbestos-Associated Diseases, 2nd ed. New York: Springer, 2004. pp. 402–10.
Rogers, AJ, Leigh, J, Berry, G, et al. Relationship between lung asbestos fiber type and concentration and relative risk of mesothelioma: a case control study. Cancer 1992;67:1912–20.
Dodson, RF, Graef, M, Shepherd, S, O'Sullivan, M, Levin, J.Asbestos burden in cases of mesothelioma from individuals from various regions of the United States. Ultrastruct Pathol 2005;29:415–33.
Gylseth, B, Mowe, G, Skaug, V, Wannag, A.Inorganic fibers in lung tissue from patients with pleural plaques or malignant mesothelioma. Scand J Work Environ Health 1981;7:109–13.
McDonald, JC, Armstrong, B, Case, B, et al. Mesothelioma and asbestos fiber type: evidence from lung tissue analyses. Cancer 1989;63:1544–7.
Steel, EB, Small, JA.Accuracy of transmission electron microscopy for the analysis of asbestos in ambient environments. Anal Chem 1985;57:209–13.
Davis, JMG, Jones, AD.Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats. Br J Exp Pathol 1988;69:717–37.
Stanton, MF, Layard, M, Tegeris, A, et al. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous mineralsJ Natl Cancer Inst 1981;67:965–75.
Berman, DW, Crump, KS, Chatfield, EJ, Davis, JM, Jones, AD.The sizes, shapes and mineralogy of asbestos structures that induce lung tumors or mesothelioma in AF/HAN rats following inhalation. Risk Anal 1995;15:181–95.
Roberson, KT, Thomas, TC, Sherman, LR.Comparison of asbestos air samples by SEM-EDXA and TEM-EDXA. Ann Occup Hyg 1992;36:265–9.
Zenker, FA. Ueber Staubinhalations Krankheiten der Lungen. (About dust inhalation diseases of the lung.) Deutsche Arch Klin Med 1867.
Brody, AR, Roe, MW.Deposition pattern of inorganic particles at the alveolar level of the lungs of rats and mice. Am Rev Respir Dis 1983;128:724–9.
Cherniack, M.Hawks Nest Incident. New Haven: Yale University Press, 1986.
Langer, AM.Crystal faces and cleavage planes in quartz as templates in biological processes. Q Rev Biophys 1978;2:543–75.
Abraham, JL.Recent advances in pneumoconiosis: the pathologists' role in etiologic diagnosis. In Thurlbeck, M, ed. The Lung: Structure, Function, and Disease. IAP Monograph 19. Baltimore: Williams & Wilkins, 1978. pp. 96–137.
Roggli, VL, Mastin, JP, Shelburne, JD, Roe, M, Brody, AR.Inorganic particulates in human lung: relationship to the inflammatory response. In Lynn, WS, ed. Inflammatory Cells and Lung Disease. Boca Raton: CRC Press, 1983. pp. 29–62.
Pratt, PC.Lung dust content and response in guinea pigs inhaling three forms of silica. Arch Environ Health 1983;38:197–204.
Le Bouffant, L, Daniel, H, Martin, JC, Gruyere, S.Effects of impurities and associated minerals on quartz toxicity. Ann Occup Hyg 1982;26:625–34.
Vallyathan, V, Shi, X, Dalal, NS, Irr, W, Castronova, V.Generation of free radicals from freshly fractured silica dust: potential role in silica-induced lung injury. Am Rev Respir Dis 1988;138:1213–19.
Rimal, B, Greenberg, AK, Rom, WN.Basic pathogenetic mechanisms in silicosis: current understanding. Curr Opin Pulm Med 2005;11(2):169–73.
Gibbs, AR, Wagner, JC.Diseases due to silica, Chapter 7. In Churg, A, Green, FHY, eds. Pathology of Occupational Lung Disease, 2nd ed. Baltimore: Williams & Wilkins, 1998.
Hamilton, RF, Thakur, SA, Holian, A.Silica binding and toxicity in alveolar macrophages. Free Radic Biol Med 2008;44:1246–58.
Absher, M, Mortara, M.Effect of silica on the proliferative behavior of human lung fibroblasts. In Vitro 1980;16:371–6.
Kleinerman, J.The pathology of some familiar pneumoconioses. Semin Roentgenol 1967;2:244–64.
Travis, WD, Colby, TV, Koss, MN, et al. eds. Occupational lung diseases and pneumoconioses, Chapter 16. In Non-Neoplastic Disorders of the Lower Respiratory Tract. Atlas of Non-tumor Pathology, First Series, Fascicle 2. Washington DC: American Registry of Pathology, 2002.
Chong, S, Lee, KS, Chung, MJ, et al. Pneumoconiosis: comparison of imaging and pathologic findings. Radiographics 2006;26:59–77.
Slavin, RE, Swedo, JL, Brandes, D, Gonzalez-Vitale, JC, Osornio-Vargas, A.Extrapulmonary silicosis: a clinical, morphologic, and ultrastructural study. Hum Pathol 1985;16:393–412.
Miranda, RN, McMillan, PN, Pricolo, VE, Finkelstein, SD.Peritoneal silicosis. Arch Pathol Lab Med 1996;120:300–2.
McDonald, JW, Roggli, VL.Detection of silica particles in lung tissue by polarized light microscopy. Arch Pathol Lab Med 1995;119:242–6.
Kleinerman, J, Green, F, Laquer, WM, et al. Pathology standards for coal workers pneumoconiosis. Arch Pathol Lab Med 1979;103:375–432.
Buechner, HA, Ansari, A.Acute silico-proteinosis. Dis Chest 1969;55:274–84.
Heppleston, AG, Wright, NA, Steward, JA.Experimental alveolar lipoproteinosis following the inhalation of silica. J. Pathol 1970;101:293–307.
Marchiori, E, Souza, CA, Barbassa, TG, Escuissato, D, Gasparetto, EL.Souza, AS.Silicoproteinosis: high resolution CT findings in 13 patients. Am J Roentgenol 2007;189:1402–6.
Miller, RR, Churg, AM, Hutcheon, M, Lom, S.Pulmonary alveolar proteinosis and aluminum dust exposure. Am Rev Respir Dis 1984;130:312–15.
Parks, CG, Conrad, K, Cooper, GS.Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 1999;107(suppl 5):793–802.
Hnizdo, E, Murray, JD.Risk of pulmonary tuberculosis relative to silicosis and exposure to silica dust in South African goldminers. Occup Environ Med 1998;55:496–502.
Otsuki, T, Maeda, M, Murakami, S, Hayashi, H, et al. Immunological effects of silica and asbestos. Cell Mol Immunol 2007;4:261–8.
Craighead, JE, Kleinerman, J.Abraham, JL, et al. Diseases associated with exposure to silica and nonfibrous silicate minerals. Arch Pathol Lab Med 1988;112:673–720.
Caplan, A.Certain unusual radiological appearances in the chest of coal miners suffering from rheumatoid arthritis. Thorax 1953;8:29–37.
Caplan, A, Payne, RB, Withey, JL.A broader concept of Caplan's syndrome related to rheumatoid factors. Thorax 1962;17:205–12.
International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 68. Silica, some silicates, coal dust and paraaramid fibrils. Lyon: IARC, 1997.
Goldsmith, DF, Winn, DM, Shy, CM, eds. Silica, Silicosis and Cancer: Controversy in Occupational Medicine. Cancer Research Monographics. New York: Praeger, 1986.
Ding, M, Chen, F, Shi, X, Yucasoy, B, Vallyathan, V.Diseases caused by silica: mechanisms of injury and disease development. Int Immunopharmacaol 2002;2:L173–82.
Saffioti, U, Williams, LN, Daniel, E, et al. Carcinogenesis by crystalline silica: animal, cellular and molecular studies. In Castronova, V, Vallyathan, V, Wallace, WE, eds. Silica and Silica-induced Disease. Boca Raton: CRC Press, 1995. pp. 345–82.
Hessel, PA, Gamble, JF, Gee, JB, et al. Silica, silicosis and lung cancer: a response to a recent working group report. J Occup Environ Med 2001;43:198–201.
Craighead, JE.Do asbestos and silica cause lung cancer?Arch Pathol Lab Med 1992;116:16–20.
Moshammer, M, Neuberger, N.Lung cancer and dust exposure: results of a prospective cohort study following 3260 workers for 50 years. Occup Environ Med 2004;61:157–62.
Pelucchi, C, Pira, E, Piolatto, G, et al. Occupational silica exposure and lung cancer risk: a review of epidemiologic studies 1996–2005. Ann Oncol 2006;17:1039–150.
Yu, TS, Tse, LA, Leung, CC, et al. Lung cancer mortality among silicotic workers in Hong Kong-no evidence for a link. Ann Oncol 2007;18:1056–63.
Bang, KM, Attfield, MD, Wood, JM, Syamial, G.National trends in silicosis mortality in the United States 1981–2004. Am J Ind Med 2008;51:633–9.
Harding, HE, Gloyne, RS, McLaughlin, AI G.Industrial Diseases in Iron and Steel Foundry Workers. London: HM Stationery Office, 1950.
Harding, HE, Gloyne, RS, McLaughlin, AI G.Pulmonary fibrosis in non-ferrous foundry workers. Br J Ind Med 1955;12:92–9.
Mason, GR, Abraham, JL, Hoffman, L, et al. Treatment of mixed dust pneumoconiosis with whole lung lavage. Am Rev Respir Dis 1982;126:1102–7.
Honma, K, Abraham, JL, Chiyotani, K, et al. Proposed criteria for mixed dust pneumoconiosis: definition, descriptions and guidelines for pathologic diagnosis and clinical correlation. Hum Pathol 2004;35:1515–23.
Mark, GJ, Monroe, CB, Kazemi, H.Mixed pneumoconiosis: silicosis, asbestosis, talcosis and berylliosis. Chest 1979;75:726–8.
.
CDC. Criteria for a Recommended Standard: Occupational Exposure to Coal Mine Dust. Cincinnati OH: US Department of Health and Human Services CDC; 1995, DHHS publication no. (NIOSH) 95–106.
Ross, MH, Murray, J.Occupational respiratory disease in mining. Occup Med 2004;54;304–10.
National Institute for Occupational Safety and Health The Work-related Lung Disease Surveillance Report 2002. Cincinatti OH: NIOSH, 2003.
Cohen, R, Velho, V.Update on respiratory disease from coal mine and silica dust. Clin Chest Med 2003;23:811–26.
Antao, VC dos S, Petsonk, EL, Sokolow, LZ, et al. Rapidly progressive coalworkers' pneumoconiosis in the United States: geographic clustering and other factors. Occup Environ Med 2005;62:670–4.
Schins, RP F, Borm, PJ A.Mechanisms and mediators in coal-induced toxicity: a review. Ann Occup Hyg 1999;43:7–33.
Adamson, YR, Bowden, DH.Role of monocytes and interstitial cells in the generation of alveolar macrophages II. Kinetic studies after carbon loading. Lab Invest 1980;42:518–24.
Heppleston, AG.The pathological anatomy of simple pneumoconiosis in coal workers. J Pathol Bacteriol 1953;66:235–46.
Li, K, Keeling, B, Churg, A.Mineral dusts cause elastin and collagen breakdown in the rat lung: a potential mechanism of dust-induced emphysema. Am J Respir Crit Care Med 1996;153:644–9.
Pratt, PC.Role of silica in progressive massive fibrosis. Arch Environ Health 1968;16:734–7.
Pratt, PC, Kilburn, KH.Extent of pulmonary pigmentation as an indicator of particulate environmental air pollution. Inhaled Part Vap 1971;2:661–70.
Watson, AJ, Black, J, Doig, AT, Nagelschmidt, G.Pneumoconiosis in carbon electrode makers. Br J Ind Med 1959;16:274–85.
Green, FHY, Vallyathan, V.Coalworkers pneumoconiosis and pneumoconiosis due to other carbonaceous dusts, Chapter 6. In Churg, A, Green, FHY, eds. Pathology of Occupational Lung Disease, 2nd ed. Baltimore: Williams & Wilkins, 1998.
McConnochie, K, Green, FHY, Vallyathan, V, et al. Interstitial fibrosis in coalworkers: experience in Wales and West Virginia. Ann Occup Hyg 1988;32:553–60.
Brichet, A, Wallert, B, Gosselin, B, et al. Idiopathic-like pulmonary fibrosis in coal workers. Am J Respir Crit Care Med 1997;155:A331.B.
Coultas, DB, Zumwalt, RE, Black, WC, Sobonya, RE.The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994;150:967–72.
Marine, WM, Gurr, D, Jacobsen, M.Clinically important respiratory effects of dust exposure and smoking in British coal miners. Am Rev Respir Dis 1988;137:106–12.
Rom, WN, Kanner, RE, Renzetti, AD, et al. Respiratory disease in Utah coal miners. Am Rev Respir Dis 1981;123:372–7.
Ames, RG, Amandus, H, Attfield, M, Green, FY, Vallyathan, V.Does coal mine dust present a risk for lung cancer? A Case-control study of U.S. coal miners. Arch Environ Health 1983;38:331–3.
Swaen, GM, Meijers, JM, Slangen, JJ.Risk of gastric cancer in pneumoconiotic coal miners and the effect of respiratory impairment. Occup Environ Med 1995;52:606–10.
Vallyathan, NV, Green, FHY, Rodman, NF, Boyd, CB, Althouse, R.Lung carcinoma by histologic type in coal miners. Arch Pathol Lab Med 1985;109:419–23.
Green, FHY, Churg, A.Diseases due to non-asbestos silicates. In Churg, A, Green, FHY, eds. Pathology of Occupational Lung Disease, 2nd ed. Baltimore: Williams & Wilkins 1998 pp. 235–76.
Vallyathan, NV.Pneumoconiosis. Respir Ther 1980;10:34–9.
Schepers, GWH, Durkan, TM.Experimental study of the effects of talc dust on animal tissue. Arch Ind Health 1955;12:317–28.
Vallyathan, NV, Craighead, JE.Pulmonary pathology in workers exposed to nonasbestiform talc. Hum Pathol 1981;12:28–35.
Feigin, D.Talc: understanding its manifestations in the chest. Am J Roentgenol 1986;146:295–301.
Hollinger, MA.Pulmonary toxicity of inhaled and intravenous talc. Toxicol Lett 1990;52:121–7.
Flors, l, Domingo, ML, Mazon, M, et al. Uncommon occupational lung diseases: high-resolution CT findings. Am J Roentgenol 2010;194:20–6.
Akira, M, Kozuka, T, Yamamoto, S, Sakatani, M, Morinaga, K.Inhalational talc pneumoconiosis: radiographic and CT findings in14 patientsAm J Roentgenol 2007;188:326–33.
Berner, A, Glyseth, B, Levy, F.Talc dust pneumoconiosis. Acta Pathol Microbiol Scand 1981; 89A:17–21.
Tomashefski, JF, Hirsch, CS.The pulmonary vascular lesions of intravenous drug abuse. Hum Pathol 1980;11:133–45.
Abraham, JL, Brambilla, C.Particle size for differentiation between inhalation and injection pulmonary talcosis. Environ Res 1980;21:94–6.
Williams, WJ.The pathology of pulmonary sarcoidosis. Proc R Soc Med 1967;60:986–8.
Crouch, E, Churg, A.Progressive massive fibrosis of the lung secondary to intravenous injection of talc. A pathologic and mineralogic analysis. Am J Clin Pathol 1983;80:520–6.
Kleinfeld, M, Messite, J, Zaki, MH.Mortality experiences among talc workers: a follow-up study. J Occup Med 1974;16:345–9.
Wild, P.Lung cancer risk and talc not containing asbestiform fibers: a review of the epidemiologic evidence. Occup Environ Med 2006;63:4–9.
Brody, AR, Craighead, JE.Cytoplasmic inclusions in pulmonary macrophages of cigarette smokers. Lab Invest 1975;32:125–32.
White, R, Kuhn, C.Effects of phagocytosis of mineral dusts on elastase secretion by alveolar and peritoneal exudative macrophages. Arch Environ Health 1980;35:106–9.
King, EJ, Harrison, CV.The effects of kaolin on the lungs of rats. J Pathol Bacteriol 1948;60:435–40.
Sabu, AP, Shaker, R, Zaidi, SH.Pulmonary response to kaolin, mica and talc in mice. Exp Pathol 1978;16:276–82.
Sepulveda, M-J, Vallyathan, V, Attfield, MD, Placitelli, L, Tucker, JH.Pneuomoconiosis and lung function in a group of kaolin workers. Am Rev Respir Dis 1983;127:231–5.
Lapenas, D, Gale, P, Kennedy, T, Rawlings, W, Dietrich, P.Kaolin pneumoconiosis: radiologic, pathologic, and mineralogic findings. Am Rev Respir Dis 1984;130:282–8.
Kennedy, T, Rawlings, W, Baser, JR M, Tockman, M.Pneumoconiosis in Georgia kaolin workers. Am Rev Respir Dis 1983;1127:215–20.
Morgan, WK C, Donner, A, Higgins, IT T, Pearson, MG, Rawlings, WThe effects of kaolin on the lung. Am Rev Respir Dis 1988;138:813–20.
Skulberg, KR, Gylseth, B, Skaug, V, Hanoa, R.Mica pneumoconiosis: a literature review. Scand J Work Environ Health 1986;11:65–74.
Zinman, C, Richards, GA, Murray, J, et al. Mica dust as a cause of severe pneumoconiosis. Am J Ind Med 2002;41:139–44.
Green, FHY, Churg, A.Diseases due to nonasbestos silicates, Chapter 8. In Churg, A, Green, FHY, eds. Pathology of Occupational Lung Disease, 2nd ed. Baltimore: Williams &Wilkins, 1998.
Lockey, JE.Nonasbestos fibrous minerals. Clin Chest Med 1981;2:203–18.
Pooley, FD.Evaluation of fiber samples taken from the vicinity of two villages in Turkey. In Lemen, R, Dement, JM, eds. Dusts and Disease: Occupational and Environmental Exposures to Selected Fibrous and Particulate Dusts. Park Forest South: Pathotox, 1979, pp. 339–44.
Suzuki, Y.Carcinogenic and fibrogenic effects of zeolites: preliminary observations. Environ Res 1982;27:433–45.
Saffioti, U.Mesothelioma carcinogenesis: in vivo models. In Pass, HI, Voglezang, NJ, Carbone, M, eds. Malignant Mesothelioma. New York: Springer, 2005. p. 60.
Emri, S, Demir, A, Dogan, M, Bozkurt, B, Carbone, M, Baris, I.Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicol Lett 2002;127:251–7.
Baris, YI.Fibrous zeolite (erionite)-related diseases in Turkey. Am J Ind Med 1991;19:374–8.
Dumortier, P, Coplu, L, Broucke, I, et al. Erionite bodies and fibres in bronchoalveolar lavage fluid of residents of Tuzkoy, Cappadocia, Turkey Occup Environ Med 2001;58:261–6.
Sebastien, P, Gaudichet, A, Bignon, J, Baris, YI.Zeolite bodies in human lungs from Turkey. Lab Invest 1981;44:420–5.
Sullivan, PA.Vermiculite, respiratory disease and asbestos exposure in Libby Montana: update of a cohort mortality study. Environ Health Perspect 2007;115:579–85.
Moatamed, F, Lockey, JE, Parry, WT.Fiber contamination of vermiculites: a potential occupational and environmental health hazard. Environ Res 1986;41:207–18.
McDonald, JC, Harris, J, Armstrong, B.Mortality in a cohort of vermiculite miners exposed to fibrous amphibole in Libby, Montana. Occup Environ Med 2004;61:363–6.
Hunter, B, Thomson, C.Evaluation of tumorigenic potential of vermiculite in rats. Br J Ind Med 1973;30:167–73.
Lang, L.Beryllium. A chronic problem. Environ Health Perspect 1994;102:526–31.
Maier, LAGenetic and exposure risks for chronic beryllium disease. Clin Chest Med 2002;23:827–39.
Kreiss, K, Day, GA, Schuler, CR.Beryllium: a modern industrial hazard. Annu Rev Public Health 2007;28:259–77.
Cummings, KJ, Stefaniak, AB, Abbas, Virji M, Kreiss, K.A reconsideration of acute beryllium disease. Environ Health Perspect 2009;117:1250–6.
Sanderson, WT.The US population at risk to occupational respiratory disease. In Merchant, JA, ed. Occupational Respiratory Disease. Publication no. 86–102. Department of Health and Human Services (NIOSH), 1986. pp. 739–59.
Newman, LS, Mroz, MM, Balkissoon, R, Maier, LA.Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of risk. Am J Respir Crit Care Med 2005;171:54–60.
Meyer, KC.Beryllium and lung disease. Chest 1994;106:942–6.
Maier, LA, Martyny, JW, Liang, J, Rossman, MD.Recent chronic beryllium disease in residents surrounding a beryllium facility. Am J Respir Crit Care Med 2008;177:1012–107.
Eisenbud, M.Origins of the standards for control of beryllium disease (1947–1949). Environ Res 1982;27:79–88.
Jones-Williams, W.A histological study of the lungs in 52 cases of chronic beryllium disease. Br J Ind Med 1958;15:84–91.
Newman, LS, Kreiss, K.Non-occupational beryllium disease masquerading as sarcoidosis: identification of blood lymphocyte proliferative response to beryllium. Am Rev Respir Dis 1992;145:1212–14.
Butnor, KJ, Sporn, TA, Ingram, P, et al. Beryllium detection in human lung tissue using electron probe X-ray microanalysis. Mod Pathol 2003;16:1171–7.
Newman, LS.Metals that cause sarcoidosis. Semin Respir Infect 1998;13:212–20.
McDonald, JW, Roggli, VL, Churg, A, Shelburne, JD.Microprobe analysis in pulmonary pathology. In Ingram, P, Shelburne, J, Roggli, V, LeFurgey, A, eds. Biomedical Applications of Microprobe Analysis. San Diego: Academic Press, 1999. pp. 201–56.
Mancuso, TF.Occupational lung cancer among beryllium workers. In Lemen, R, Dement, DM, eds. Dusts and Disease: Occupational and Environmental Exposures to Selected Fibrous and Particulate Dusts. Park Forest South: Pathotox, 1979. pp. 463–71.
Infante, JK, Sprince, NL.Bronchogenic cancer and non-neoplastic respiratory disease associated with beryllium exposure. In Lemen, R, Dement, DM, eds. Dusts and Disease: Occupational and Environmental Exposures to Selected Fibrous and Particulate Dusts. Park Forest South: Pathotox, 1979. pp. 473–82.
Liebow, AA.Definition and classification of interstitial pneumonias in human pathology. Prog Respir Res 1975;8:1–31.
Nemery, B, Verbeken, E, Demedts, M.Giant cell interstitial pneumonia (hard metal lung disease, cobalt lung). Semin Resp Crit Care Med 2001;22:435–47.
Balmes, JR.Respiratory effects of hard metal dust exposure. Occup Med 1987;2:327–44.
Schepers, GW H.The biological action of tungsten carbide and cobalt: studies on experimental pulmonary histopathology. Arch Ind Health 1955;12:140–6.
Lison, D, Lauwerys, R, Demedts, M, Nemery, B.Experimental research into the pathogenesis of cobalt/hard metal lung disease. Eur Respir J 1996;9:1024–8.
Kelleher, P, Pacheco, K, Newman, LS.Inorganic dust pneumonias: the metal-related parenchymal disorders. Environ Health Perspect 2000;108(suppl 4):685–96.
Moriyama, H, Kobayasahi, M, Takada, T, et al. Two dimensional analysis of elements and mononuclear cells in hard metal lung disease. Am J Respir Crit Care Med 2007;176:70–7.
Potoliocchio, I, Mosconi, G, Forni, A, et al. Susceptibility to hard metal lung disease is strongly associated with the presence of glutamate 69 in HLA DP-beta chain. Eur J Immunol 1997;27:2741–3.
Sprince, NL, Oliver, LC, Eisen, EA, Greene, RE, Chamberlin, RI.Cobalt exposure and lung disease in tungsten carbide production: a cross-sectional study of current workers. Am Rev Respir Dis 1988;138:1220–6.
Sprince, NL, Chamberlin, RI, Hales, CA, Weber, AL, Kazemi, H.Respiratory disease in tungsten carbide production workers. Chest 1984;86:549–57.
Dunlop, P, Müller, NL, Wilson, J, Churg, A.Hard metal lung disease: high resolution CT and histologic correlation of the initial findings and demonstration interval improvement. J Thorac Imaging 2005;20:301–4.
Akira, M.Uncommon pneumoconioses: CT and pathologic findings. Radiology 1995;197:403–9.
Tabatowski, K, Roggli, VL, Fulkerson, WJ, et al. Giant cell interstitial pneumonia in a hard-metal worker: cytologic, histologic, and analytical electron microscopic investigation. Acta Cytol 1988;32:240–6.
Kinoshita, M, Sueyasu, Y, Watanabe, H, et al. Giant cell interstitial pneumonia in two hard metal workers: the role of bronchoalveolar lavage in diagnosis. Respirology 1999;4:263–6.
Ohori, NP, Sciurba, FC, Owens, GR, Hodgson, MJ, Yousem, SA.Giant-cell interstitial pneumonia and hard metal pneumoconiosis: a clinicopathologic study of four cases and review of the literature. Am J Surg Pathol 1989;13:581–7.
Nagvi, A, Hunt, A, Burnett, BR, Abraham, JL.Pathologic spectrum and lung dust burden in giant cell interstitial pneumonia (hard metal disease/cobalt pneumoconiosis): Arch Environ Occup Health 2008;63:51–70.
Coates, EO, Watson, JH L.Diffuse interstitial lung disease in tungsten carbide workers. Ann Intern Med 1971;75:709–16.
Buerke, U, Schneider, J, Rosler, J, Woitowitz, H-J.Interstitial pulmonary fibrosis after severe exposure to welding fumes. Am J Ind Med 2002;41:259–68.
Heath, D, Mooi, W, Smith, P.The pulmonary vasculature in hematite lung. Br J Dis Chest 1978;72:88–94.
Gardner, LU.Studies on the relationship of mineral dusts to tuberculosis. Am Rev Tuberc 1923;71:344–57.
McDonald, JW, Ghio, AJ, Sheehan, CE, Bernhardt, P, Roggli, VL.Rare earth (cerium oxide) pneumoconiosis: analytical scanning electron microscopy and literature review. Mod Pathol 1995;8:859–65.
Palmer, RJ, Butenhoff, JL, Stevens, JB.Cytotoxicity of the rare earth metals cerium, lanthanum and neodymium in vitro: comparison with cadmium in a pulmonary macrophage culture system. Environ Res 1987;43:142.
Selden, A, Sahle, W, Johansson, L, Sorenso, S, Persson, B.Three cases of dental technicians pneumoconiosis related to cobalt chromium molybdenum dust exposure. Chest 1996;109:837–42.
De Vuyst, P, Vande Weyer, R, De Coster, A, et al. Dental technicians pneumoconiosis: a report of two cases. Am Rev Respir Dis 1986;133:316–20.
Selden, A, Persson, B, Bornberger-Dankvardt, SI, Winstrom, LE.Exposure to cobalt chromium dust and lung disorders in dental technicians. Thorax 1995;50:769–72.
Barrett, TE, Pietra, GG, Maycock, RL, et al. Acrylic resin pneumoconiosis: Report of a case in a dental student. Am Rev Respir Dis 1989;139:841–84.
Ophus, EM, Rode, L, Gylseth, B, Nicholson, DG, Saeed, K.Analysis of titanium pigments in human lung tissue. Scand J Work Environ Health 1979;5:290–6.
Crouch, E, Churg, A.Ferruginous bodies and the histologic evaluation of dust exposure. Am J Surg Pathol 1984;8:109–16.
Doig, AT.Baritosis: a benign pneumoconiosis. Thorax 1976;31:30–9.
Sferlazza, SJ, Beckett, WS.The respiratory health of welders. Am Rev Respir Dis 1991;143:1134–48.
Antonini, JM.Health effects of welding. Crit Rev Toxicol 2002;33:61–103.
Chen, W-J, Monnat, RJ, Chen, M, Moffett, NK.Aluminum induced pulmonary granulomatosis. Hum Pathol 1978;9:705–11.
Hull, MJ, Abraham, J.Aluminum welding fume-induced pneumoconiosis. Hum Pathol 2002;33:819–25.
Vallyathan, V, Bergeron, WN, Robichaux, PA, Craighead, JE.Pulmonary fibrosis in an aluminum arc welder. Chest 1982;81:372–4.
Herbert, A, Sterling, G, Abraham, J, Corrin, B.Desquamative interstitial pneumonia in an aluminum welder. Hum Pathol 1982;13:694–9.
Antonini, JM, Lewis, AB, Roberts, JR, Whaley, DA.Pulmonary effects of welding fumes: review of worker and experimental animal studies. Am J Ind Med 2003;43:350–60.
International Agency for Research on Cancer (IARC). Chromium, nickel and welding fumes. IARC monographs on the evaluation of oncogenic risks to humans, vol. 49. Lyon: IARC, 1990.
Stern, RM.The assessment of risk: Application to the welding industry lung cancer. The International Institute of Welding Commission, VIII: Safety and Health Doc. IIW, VIII: 2034–2083. Copenhagen: Danish Welding Institute, 1983. pp. 1–26.
Danielson, TE, Langard, S, Andersen, A.Incidence of lung cancer among shipyard welders investigated for siderosis. Int J Occup Environ Health 1998;4:85–8.
Becker, N.Cancer mortality among arc welders exposed to fumes containing chromium and nickel. Results of a third follow up. 1989–1995. J Occup Environ Med 1999;41:294–303.
Shaver, CG, Riddell, AR.Lung changes associated with the manufacture of aluminum abrasives. J Ind Hyg Toxicol 1947;29:145–57.
Miller, R, Churg, AM, Hutcheon, M, Lam, F.Pulmonary alveolar proteinosis and aluminum dust exposure. Am Rev Respir Dis 1984;130:312–15.
Abramson, MJ, Wlodarcyk, JH, Saunders, NA, Hensley, MJ.Does aluminum smelting cause lung disease?Am Rev Respir Dis 1989;139:1042–57.
Gilks, B, Churg, A.Aluminum-induced pulmonary fibrosis: do fibers play a role?Am Rev Respir Dis 1987;136:176–9.
Newman-Taylor, AJ.Cadmium, Chapter 70. In Rom, WN, ed. Environmental and Occupational Medicine, 3rd ed. Philadelphia: Lippincott Raven, 1998. pp. 1011–21.
Kanluen, S, Gottlieb, CA.A clinical pathological study of four adult cases of acute mercury inhalational toxicity. Arch Pathol Lab Med 1991;115:56–60.
Rowens, B, Guerrero-Bettancourt, D, Gottlieb, CA, Boyes, RJ, Eichenhorn, MS.Respiratory failure and death following acute inhalation of mercury vapor. Chest 1991;99:185–90.
Churg, A.Non-asbestos pulmonary mineral fibers in the general population. Environ Res 1986;31:189–200.
Roggli, VL.Non-asbestos mineral fibers in human lungs. In Russell, PE, ed. Microbeam Analysis – 1989. San Francisco: San Francisco Press, 1989. pp. 57–9.
Baker, D, Kupke, KG, Ingram, P, Roggli, VL, Shelburne, JD.Microprobe analysis in human pathology. In Johari, O, ed. Scanning Electron Microscopy, vol. II. Chicago: SEM, 1985. pp. 659–80.
Lemasters, GK, Lockey, J, Levin, LS, et al. An industry-wide pulmonary study of men and women manufacturing refractory ceramic fibers. Am J Epidemiol 1998;148:910–19.
Lemasters, GK, Lockey, J, Rice, C, et al. Radiographic changes among workers manufacturing refractory ceramic fibre and products. Ann Occup Hyg 1994;38(suppl 1):745–51.
Lockey, J, Lemasters, G, Rice, C, et al. Refractory ceramic fiber exposure and pleural plaques. Am J Resp Cit Care Med 1996;154:1405–10.
Carel, R, Olsson, A, Zaridze, D, et al. Occupational exposure to asbestos and man-made mineral fibers and risk of lung cancer: a multicentre case-control study in Europe. Occup Environ Med 2007;64:502–8.
Kjaerheim, K, Boffetta, P, Hansen, J, et al. Lung cancer among rock and slag wool production workers. Epidemiology 2002;13:445–53.
Pohlabeln, H, Jockel, KH, Bruske-Hohlfeld, I, et al. Lung cancer and exposure to man-made vitreous fibers: results from a pooled case-control study in Germany. Am J Ind Med 2000;37:469–77.
Man-made Vitreous Fibres/IARC working group on the evaluation of carcinogenic risks to humans. IARC monographs on the carcinogenic risks to humans; 81. Lyon: IARC, 2002.
Wright, GW, Kuschner, M.The influence of varying lengths of glass and asbestos fibres on tissue response in guinea pigs. In Walton, WH, ed. Inhaled Particles IV. Oxford: Pergamon, 1977, pp. 455–74.
Morgan, A, Holmes, A, Davison, W.Clearance of sized glass fibres from the rat lung and their solubility in vivo. Ann Occup Hyg 1982;25:317–31.
McDonald, JC, Case, BW, Enterline, PE, et al. Lung dust analysis in the assessment of past exposure of man-made mineral fibers. Ann Occup Hyg 1990;324:427–41.
Enterline, PE, Marsh, GM.Environment and mortality of workers from a fibrous glass plant. In Lemen, R, Dement, DM, eds. Dusts and Disease: Occupational and Environmental Exposures to Selected Fibrous and Particulate Dusts. Park Forest South: Pathotox, 1979. pp. 221–31.
Wright, GW.Proceedings of the Second Symposium on Occupational Exposure to Fibrous Glass. Washington DC: US Government Printing Office, 1976. p. 126.
Bayliss, D, Dement, J, Wagoner, JK, Blejer, HP.Mortality patterns among fibrous glass production workers. Ann NY Acad Sci 1976;271:324–35.
Gross, P, Tuma, J, de Treville, TP.Lungs of workers exposed to fiber glass: a study of their pathologic changes and their dust content. Arch Environ Health 1971;3:67–76.
Ghio, AJ, Funkhouser, W, Pugh, CB, et al. Pulmonary fibrosis associated with exposure to synthetic fibers. Toxicol Pathol 2006;34:723–9.
Eschenbacher, WL, Kreiss, K, Lougheed, MD, et al. Nylon flock-associated interstitial lung disease. Am J Respir Crit Care Med 1999;159:2003–8.
Kern, DG, Crausman, RS, Durand, KT, et al. Flock workers lung: chronic interstitial lung disease in the nylon flocking industry. Ann Intern Med 1998;129:261–72.
Kern, DG, Kuhn, C, Ely, EW, et al. Flock workers lung: broadening the spectrum of clinicopathology, narrowing the spectrum of suspected etiologies. Chest 2000;117:251–9.
Boag, AH, Colby, TV, Fraire, AE, et al. The pathology of interstitial lung disease in nylon flock workers. Am J Surg Pathol 1999;23:1539–45.
Ramage, JE, Roggli, VL, Bell, DY, Piantadosi, CA.Interstitial lung disease and domestic wood burning. Am Rev Respir Dis 1988;137:1229–32.
McCrone, WC, ed. The Particle Atlas, vols V and VI. 2nd ed. Ann Arbor: Ann Arbor Science, 1980. pp. 1336–634.
Martin, TR, Meyer, SW, Luchtel, DR.An evaluation of the toxicity of carbon fiber composites for lung cells in vitro and in vivo. Environ Res 1989;49:246–61.
Luchtel, DL, Martin, TR, Boatman, ES.Response of the rat lung to respirable fractions of composite fiber-epoxy dusts. Environ Res 1989;48:57–69.
Shedova, AA, Kisin, ER, Porter, D, et al. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: two faces of Janus?Pharamcol Therap 2009;121:192–204.
Simeonova, PP.Update on carbon nanotube toxicity. Nanomedicine 2009;4:373–5.
Muller, J, Huaux, F, Lison, D.Respiratory toxicity of carbon nanotubes: how worried should we be?Carbon 2006;44:1048–56.
Wu, M, Gordon, RE, Herbert, R, et al. Case report: lung disease in World Trade Center responders exposed to dust and smoke: carbon nanotubes found in the lungs of World Trade Center patients and dust samples. Envrion Health Perspect 2010;118:499–504.
Lam, C-W, James, JT, McCluskey, R, Hunter, RL.Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 2004;77:126–34.
Donaldson, K, Aitekne, R, Tran, L, et al. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 2006;92:5–22.
Akpinar-Elci, A, Travis, WD, Lynch, DA, Kreiss, K.Bronchiolitis obliterans syndrome in popcorn production workers. Eur Resp J 2004;24:298–302.
Kreiss, K, Gomaa, A, Kullman, G, et al. Clinical bronchiolitis obliterans in workers at a microwave popcorn plant. N Engl J Med 2002;347:330–7.
Kanwal, R.Bronchiolitis obliterans in workers exposed to flavoring chemicals. Curr Opin Pulm Med 2008;14:141–6.
Kanwal, R, Kullman, G, Piacitelli, C, et al. Evaluation of flavorings-related lung disease risk at six microwave popcorn plants. J Occup Env Med 2006;48:149–57.
Hendrick, DJ.“Popcorn workers lung” in Britain in a man making potato crisp flavoring. Thorax 2008;63:267–8.
Hubbs, AF, Goldsmith, WT, Kashon, ML, et al. Respiratory toxicology of inhaled diacetyl in Sprague-Dawley rats. Toxicol Pathol 2008;36:330–44.
Fedan, JS, Dowdy, JA, Fedan, KB, Hubbs, AF.Popcorn workers lung: in vitro exposure to diacetyl, an ingredient in microwave popcorn butter flavoring, increases reactivity to methacholine. Toxicol Appl Pharmacol 2006;215(1):17–22.
Van Rooy, FG, Rooyackers, JM, Prokop, M, et al. Bronchiolitis obliterans syndrome in chemical workers producing diacetyl for food flavorings. Am J Respir Crit Care Med 2007;176:498–504.